Brandywine Global Investment Management’s Aquestive Therapeutics AQST Stock Holding History

Brandywine Global Investment Management’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-125,016	Closed	-$545K	–	700
2021 Q3	$545K	Sell	125,016 -400	-0.3%	-$1.57K	﹤0.01%	594
2021 Q2	$498K	Sell	125,416 -10,700	-8%	-$42.7K	﹤0.01%	599
2021 Q1	$708K	Sell	136,116 -1,500	-1%	-$7.98K	0.01%	572
2020 Q4	$736K	Buy	137,616 +587	+0.4%	+$3.52K	0.01%	543
2020 Q3	$666K	Buy	137,029 +45,900	+50%	+$300K	0.01%	511
2020 Q2	$443K	Buy	91,129 +1,700	+2%	+$7.83K	﹤0.01%	542
2020 Q1	$196K	Buy	89,429 +1,238	+1%	+$4.7K	﹤0.01%	590
2019 Q4	$532K	Buy	88,191 +24,491	+38%	+$127K	﹤0.01%	595
2019 Q3	$203K	Hold	63,700	–	–	﹤0.01%	626
2019 Q2	$268K	Buy	63,700 +44,700	+235%	+$229K	﹤0.01%	607
2019 Q1	$132K	Buy	+19,000	New	+$133K	﹤0.01%	666

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAFP

Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Latash Investments Anchorage, Alaska $129M AUM 14.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Brandywine Global Investment Management's AQST Position: Q4 2021 in Review

Brandywine Global Investment Management sold out of Aquestive Therapeutics (AQST) in Q4 2021, closing a stake of 125,016 shares — an estimated $545K sold.

Brandywine Global Investment Management first reported a position in AQST in Q1 2019 and held it in 11 quarters. The position peaked at $736K in Q4 2020. 52 funds tracked by Wall St. Rank hold AQST as of Q4 2021.

Brandywine Global Investment Management reported no remaining Aquestive Therapeutics position as of Q4 2021 after selling out during the quarter.
Brandywine Global Investment Management sold 125,016 Aquestive Therapeutics shares in Q4 2021, an estimated $545K.
Brandywine Global Investment Management first reported a position in Aquestive Therapeutics in Q1 2019 and held it in 11 quarters.
Brandywine Global Investment Management's Aquestive Therapeutics position peaked at $736K in Q4 2020.
52 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2021.

Based on Brandywine Global Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.